305 related articles for article (PubMed ID: 36056540)
21. Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
Fang F; Clemens JD; Zhang ZF; Brewer TF
PLoS One; 2024; 19(4):e0301830. PubMed ID: 38656933
[TBL] [Abstract][Full Text] [Related]
22. Protection by Vaccines and Previous Infection Against the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2.
Šmíd M; Berec L; Přibylová L; Májek O; Pavlík T; Jarkovský J; Weiner J; Barusová T; Trnka J
J Infect Dis; 2022 Oct; 226(8):1385-1390. PubMed ID: 35482442
[TBL] [Abstract][Full Text] [Related]
23. Omicron variant dominance and anti-SARS-CoV-2 vaccination are key determinants for a milder course of COVID-19 in patients with systemic autoimmune rheumatic diseases.
Papagoras C; Zioga N; Papadopoulos V; Gerolymatou N; Kalavri E; Bounos C; Simopoulou T; Fragoulis GE; Panopoulos S; Fragiadaki K; Evangelatos G; Bournia VK; Arida A; Karamanakos A; Pappa M; Kravvariti E; Deftereou K; Kougkas N; Zampeli E; Kataxaki E; Melissaropoulos K; Barouta G; Panagiotopoulos A; Koutsianas C; Liossis SN; Georgiou P; Dimitroulas T; Tektonidou MG; Bogdanos DP; Elezoglou A; Voulgari PV; Sfikakis PP; Vassilopoulos D
Clin Rheumatol; 2023 Dec; 42(12):3375-3385. PubMed ID: 37731083
[TBL] [Abstract][Full Text] [Related]
24. A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.
Li JX; Liao PL; Wei JC; Hsu SB; Yeh CJ
Front Public Health; 2023; 11():1143650. PubMed ID: 37799149
[TBL] [Abstract][Full Text] [Related]
25. Vaccine effectiveness against Delta, Omicron BA.1, and BA.2 in a highly vaccinated Asian setting: a test-negative design study.
Tan CY; Chiew CJ; Pang D; Lee VJ; Ong B; Lye DC; Tan KB
Clin Microbiol Infect; 2023 Jan; 29(1):101-106. PubMed ID: 36028091
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of mRNA COVID-19 vaccines against Omicron and Delta variants in a matched test-negative case-control study among US veterans.
Young-Xu Y; Zwain GM; Izurieta HS; Korves C; Powell EI; Smith J; Balajee A; Holodniy M; Beenhouwer DO; Rodriguez-Barradas MC; Brown ST; Marconi VC
BMJ Open; 2022 Aug; 12(8):e063935. PubMed ID: 35922100
[TBL] [Abstract][Full Text] [Related]
27. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome.
Robinson ML; Morris CP; Betz JF; Zhang Y; Bollinger R; Wang N; Thiemann DR; Fall A; Eldesouki RE; Norton JM; Gaston DC; Forman M; Luo CH; Zeger SL; Gupta A; Garibaldi BT; Mostafa HH
Clin Infect Dis; 2023 May; 76(9):1539-1549. PubMed ID: 36528815
[TBL] [Abstract][Full Text] [Related]
28. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
[TBL] [Abstract][Full Text] [Related]
29. The identification and phylogenetic analysis of SARS-CoV-2 delta variants in Taiwan.
Liu LT; Tsai JJ; Chu JJH; Chen CH; Chen LJ; Lin PC; Tsai CY; Hsu MC; Chuang WL; Hwang SJ; Chong IW
Kaohsiung J Med Sci; 2023 Jun; 39(6):624-636. PubMed ID: 36951529
[TBL] [Abstract][Full Text] [Related]
30. [Effect of the Omicron variant on cumulative incidence of infection and lethality during the sixth wave of the COVID-19 epidemic in Spain].
Serrano-Cumplido A; Ruíz-García A; Del Rio-Herrero A; Antón-Eguía PB; Micó-Pérez RM; Calderón-Montero A; Romero-Rodríguez E; Segura-Fragoso A; Martín-Sánchez V
Semergen; 2024 Mar; 50(2):102073. PubMed ID: 37839336
[TBL] [Abstract][Full Text] [Related]
31. Clinical Characteristics and Outcomes of Children With SARS-CoV-2 Infection During the Delta and Omicron Variant-Dominant Periods in Korea.
Choi SH; Choi JH; Lee JK; Eun BW; Song SH; Ahn B; Kim YK; Yun KW
J Korean Med Sci; 2023 Mar; 38(9):e65. PubMed ID: 36880106
[TBL] [Abstract][Full Text] [Related]
32. Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants.
Chiu CH; Chang YH; Tao CW; Chang FY; Chiu KC; Chang TW; Yen LC
Microbiol Spectr; 2022 Oct; 10(5):e0060922. PubMed ID: 36005765
[TBL] [Abstract][Full Text] [Related]
33. RNA loads of severe acute respiratory syndrome coronavirus 2 in patients with breakthrough coronavirus disease 2019 caused by the Delta and Omicron variants.
de Michelena P; Torres I; Ferrando EC; Olea B; González-Candelas F; Sánchez G; Navarro D
Clin Microbiol Infect; 2023 Feb; 29(2):256.e1-256.e4. PubMed ID: 36115649
[TBL] [Abstract][Full Text] [Related]
34. Relative instantaneous reproduction number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
Ito K; Piantham C; Nishiura H
J Med Virol; 2022 May; 94(5):2265-2268. PubMed ID: 34967453
[TBL] [Abstract][Full Text] [Related]
35. Augmented neutralization of SARS-CoV-2 Omicron variant by boost vaccination and monoclonal antibodies.
Schulz SR; Hoffmann M; Roth E; Pracht K; Burnett DL; Mazigi O; Schuh W; Manger B; Mielenz D; Goodnow CC; Christ D; Pöhlmann S; Jäck HM
Eur J Immunol; 2022 Jun; 52(6):970-977. PubMed ID: 35253229
[TBL] [Abstract][Full Text] [Related]
36. Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
Ong DSY; de Man P; Verhagen T; Doejaaren G; Dallinga MA; Alibux E; Janssen ML; Wils EJ
J Med Virol; 2023 Apr; 95(4):e28748. PubMed ID: 37185846
[TBL] [Abstract][Full Text] [Related]
37. Impacts of delta and omicron variants on inactivated SARS-CoV-2 vaccine-induced T cell responses in patients with autoimmune diseases and healthy controls.
Wang S; Li J; Wang S; Ye Y; Li M; Liu Y; Chen B; Lai Y; Li L; Zhuang L; Peng S; Yang N; Zhang H; Xiao H
Clin Transl Med; 2023 Jan; 13(1):e1171. PubMed ID: 36639826
[TBL] [Abstract][Full Text] [Related]
38. The Vaccine Efficacy Against the SARS-CoV-2 Omicron: A Systemic Review and Meta-Analysis.
Zou Y; Huang D; Jiang Q; Guo Y; Chen C
Front Public Health; 2022; 10():940956. PubMed ID: 35910897
[TBL] [Abstract][Full Text] [Related]
39. Reduction in Chest CT Severity and Improved Hospital Outcomes in SARS-CoV-2 Omicron Compared with Delta Variant Infection.
Tsakok MT; Watson RA; Saujani SJ; Kong M; Xie C; Peschl H; Wing L; MacLeod FK; Shine B; Talbot NP; Benamore RE; Eyre DW; Gleeson F
Radiology; 2023 Jan; 306(1):261-269. PubMed ID: 35727150
[TBL] [Abstract][Full Text] [Related]
40. Risk of severe COVID-19 in unvaccinated patients during the period from wild-type to Omicron variant: real-world evidence from Japan.
Tomioka K; Uno K; Yamada M
Environ Health Prev Med; 2024; 29():10. PubMed ID: 38447970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
